Allogeneic CAR T Cells CT0594CP

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of allogeneic T-lymphocytes that have been genetically modified to express chimeric antigen receptors (CARs) specific for as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic CAR T cells CT0594CP specifically targets and binds to tumor cells that express the undisclosed TAAs, resulting in tumor cell lysis.

**Synonyms:** - Allogeneic CAR T-cells CT0594CP - Allogeneic CAR-T Cells CT0594CP - CT 0594CP - CT-0594CP - CT0594CP